Neuropathic damage in the diabetic eye: clinical implications

Tesfaye, 2010, Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments, Diabetes Care, 33, 2285, 10.2337/dc10-1303 Pop-Busui, 2017, Diabetic neuropathy: a position statement by the American diabetes association, Diabetes Care, 40, 136, 10.2337/dc16-2042 Sadosky, 2013, Burden of illness associated with painful diabetic peripheral neuropathy among adults seeking treatment in the US: results from a retrospective chart review and cross-sectional survey, Diabetes Metab Syndr Obes, 6, 79, 10.2147/DMSO.S37415 Dyck, 2014, Multicenter trial of the proficiency of smart quantitative sensation test, Muscle Nerve, 49, 645, 10.1002/mus.23982 Simó, 2014, Neurodegeneration in the diabetic eye, new insights and therapeutic perspectives, Trends Endocrinol Metab, 25, 23, 10.1016/j.tem.2013.09.005 Carrasco, 2007, Lower somatostatin expression is an early event in diabetic retinopathy and is associated with retinal neurodegeneration, Diabetes Care, 30, 2902, 10.2337/dc07-0332 Garcia-Ramírez, 2009, Interphotoreceptor retinoid-binding protein (IRBP) is downregulated at early stages of diabetic retinopathy, Diabetologia, 52, 633, 10.1007/s00125-009-1548-8 Kern, 2008, Retinal ganglion cells in diabetes, J Physiol, 586, 4401, 10.1113/jphysiol.2008.156695 Kern, 2015, Photoreceptors in diabetic retinopathy, J Diabetes Investig, 6, 371, 10.1111/jdi.12312 Lombardo, 2016, Investigation of adaptive optics imaging biomarkers for detecting pathological changes of the cone mosaic in patients with type 1 diabetes mellitus, PLoS One, 11, 10.1371/journal.pone.0151380 Simo, 2015, Novel approaches for treating diabetic retinopathy based on recent pathogenic evidence, Prog Retin Eye Res, 48, 160, 10.1016/j.preteyeres.2015.04.003 Sohn, 2016, Retinal neurodegeneration may precede microvascular changues characteristics of diabetic retinopathy in diabetes mellitus, Proc Natl Acad Sci U S A, 113, E2655, 10.1073/pnas.1522014113 Vujosevic, 2015, Aqueous humor biomarker of Muller cell activation in diabetic eyes, Invest Ophthalmol Vis Sci, 56, 3913, 10.1167/iovs.15-16554 Simó, 2018, Neurodegeneration in diabetic retinopathy: does it really matter?, Diabetologia, 61, 1902, 10.1007/s00125-018-4692-1 Matteucci, 2014, Neuroprotection by rat Müller glia against high glucose-induced neurodegeneration through a mechanism involving ERK1/2 activation, Exp Eye Res, 125, 20, 10.1016/j.exer.2014.05.011 Altman, 2018, The role of microglia in diabetic retinopathy: inflammation, microvascular defects and neurodegeneration, Int J Mol Sci, 19, 110, 10.3390/ijms19010110 Wu, 2014, Comparison between multifocal electroretinography and microperimetry in age-related macular degeneration, Invest Ophthalmol Vis Sci, 55, 6431, 10.1167/iovs.14-14407 Bandello, 2015, Retinal layer location of increased retinal thickness in eyes with subclinical and clinical macular edema in diabetes type 2, Ophthalmic Res, 54, 112, 10.1159/000438792 Santos, 2017, Functional and structural findings of neurodegeneration in early stages of diabetic retinopathy: cross-sectional analyses of baseline data of the EUROCONDOR project, Diabetes, 66, 2503, 10.2337/db16-1453 Picconi, 2017, Retinal neurodegeneration in patients with type 1 diabetes mellitus: the role of glycemic variability, Acta Diabetol, 54, 489, 10.1007/s00592-017-0971-4 Picconi, 2019, Activation of retinal Müller cells in response to glucose variability, Endocrine, 65, 542, 10.1007/s12020-019-02017-5 Riva, 2005, Visually evoked hemodynamical response and assessment of neurovascular coupling in the optic nerve and retina, Prog Retin Eye Res, 24, 183, 10.1016/j.preteyeres.2004.07.002 Formaz, 1997, Diffuse luminance flicker increases retinal vessel diameter in humans, Curr Eye Res, 16, 1252, 10.1076/ceyr.16.12.1252.5021 Hernández, 2012, Neuroprotection in diabetic retinopathy, Curr Diab Rep, 12, 329, 10.1007/s11892-012-0284-5 Hernández, 2016, Neuroprotection as a therapeutic target for diabetic retinopathy, J Diabetes Res, 2016, 10.1155/2016/9508541 Hernández, 2013, Topical administration of somatostatin prevents retinal neurodegeneration in experimental diabetes, Diabetes, 62, 2569, 10.2337/db12-0926 Hernández, 2016, Topical administration of GLP-1 receptor agonists prevents retinal neurodegeneration in experimental diabetes, Diabetes, 65, 172, 10.2337/db15-0443 Sampedro, 2019, New insights into the mechanisms of action of topical administration of GLP-1 in an experimental model of diabetic retinopathy, J Clin Med, 8, 339, 10.3390/jcm8030339 Hernández, 2017, Topical administration of DPP-IV inhibitors prevents retinal neurodegeneration in experimental diabetes, Diabetologia, 60, 2285, 10.1007/s00125-017-4388-y Simó, 2019, Effects of topically administered neuroprotective drugs in early stages of diabetic retinopathy: results of the EUROCONDOR clinical trial, Diabetes, 68, 457, 10.2337/db18-0682 Hafner, 2020, Retinal and corneal neurodegeneration and their association with systemic signs of peripheral neuropathy in type 2 diabetes, Am J Ophthalmol, 209, 197, 10.1016/j.ajo.2019.09.010 Tavakoli, 2015, Normative values for corneal nerve morphology assessed using corneal confocal microscopy: a multinational normative data set, Diabetes Care, 38, 838, 10.2337/dc14-2311 Edwards, 2012, Utility of corneal confocal microscopy for assessing mild diabetic neuropathy: baseline findings of the LANDMark study, Clin Exp Optom, 95, 348, 10.1111/j.1444-0938.2012.00740.x Tavakoli, 2010, Corneal confocal microscopy: a novel noninvasive test to diagnose and stratify the severity of human diabetic neuropathy, Diabetes Care, 33, 1792, 10.2337/dc10-0253 Wu, 2012, Variables associated with corneal confocal microscopy parameters in healthy volunteers: implications for diabetic neuropathy screening, Diabet Med, 29, e297, 10.1111/j.1464-5491.2012.03678.x Ziegler, 2014, Early detection of nerve fiber loss by corneal confocal microscopy and skin biopsy in recently diagnosed type 2 diabetes, Diabetes, 63, 2454, 10.2337/db13-1819 Stem, 2014, Differential reduction in corneal nerve fiber length in patients with type 1 or type 2 diabetes mellitus, J Diabetes Complications, 28, 658, 10.1016/j.jdiacomp.2014.06.007 Tavakoli, 2011, Corneal confocal microscopy detects improvement in corneal nerve morphology with an improvement in risk factors for diabetic neuropathy, Diabet Med, 28, 1261, 10.1111/j.1464-5491.2011.03372.x Tavakoli, 2012, Corneal confocal microscopy detects small-fiber neuropathy in Charcot-Marie-Tooth disease type 1A patients, Muscle Nerve, 46, 698, 10.1002/mus.23377 Tavakoli, 2009, Corneal confocal microscopy: a novel noninvasive means to diagnose neuropathy in patients with Fabry disease, Muscle Nerve, 40, 976, 10.1002/mus.21383 Campagnolo, 2013, Corneal confocal microscopy in patients with oxaliplatin-induced peripheral neuropathy, J Peripher Nerv Syst, 18, 269, 10.1111/jns5.12036 Schiano Lomoriello, 2019, Early alterations of corneaJ subasal plexus in uncomplicated type 1 diabetes patients, J Opthalmol, 2019 Perkins, 2018, Corneal confocal microscopy for identification of diabetic sensorimotor polyneuropathy: a pooled multinational consortium study, Diabetologia, 61, 1856, 10.1007/s00125-018-4653-8 Rosenberg, 2000, Corneal structure and sensitivity in type 1 diabetes mellitus, Invest Ophthalmol Vis Sci, 41, 2915 Quattrini, 2007, Surrogate markers of small fiber damage in human diabetic neuropathy, Diabetes, 56, 2148, 10.2337/db07-0285 Lewis, 2017, Using in vivo corneal confocal microscopy to identify diabetic sensorimotor polyneuropathy risk profiles in patients with type 1 diabetes, BMJ Open Diabetes Res Care, 5, 10.1136/bmjdrc-2016-000251 Williams, 2020, An artificial intelligence-based deep learning algorithm for the diagnosis of diabetic neuropathy using corneal confocal microscopy: a development and validation study, Diabetologia, 63, 419, 10.1007/s00125-019-05023-4 Markoulli, 2018, The impact of diabetes on corneal nerve morphology and ocular surface integrity, Ocul Surf, 16, 45, 10.1016/j.jtos.2017.10.006 Kim, 2016, Retinal neurodegeneration associated with peripheral nerve conduction and autonomic nerve function in diabetic patients, Am J Ophtalmol, 170, 15, 10.1016/j.ajo.2016.06.038 Salvi, 2016, Abnormalities of retinal ganglion cell complex at optical coherence tomography in patients with type 2 diabetes: a sign of diabetic polyneuropathy, not retinopathy, J Diabetes Complications, 30, 469, 10.1016/j.jdiacomp.2015.12.025 Pemp, 2018, Correlation of retinal neurodegeneration with measures of peripheral autonomic neuropathy in type 1 diabetes, Acta Ophthalmol, 96, e804, 10.1111/aos.13733 Souayah, 2009, Motor unit number estimate as a predictor of motor dysfunction in an animal model of type 1 diabetes, Am J Physiol Endocrinol Metab, 297, E602, 10.1152/ajpendo.00245.2009 de Carvalho, 2018, Motor unit number estimation (MUNE): where are we now?, Clin Neurophysiol, 8, 1507, 10.1016/j.clinph.2018.04.748 Kristensen, 2019, Detection of early motor involvement in diabetic polyneuropathy using a novel MUNE method — MScanFit MUNE, Clin Neurophysiol, 130, 1981, 10.1016/j.clinph.2019.08.003 Picconi, 2018, Association between early neuroretinal dysfunction and peripheral motor unit loss in patients with type 1 diabetes mellitus, J Diabetes Res, 2018, 10.1155/2018/9763507 Biessels, 2006, Risk of dementia in diabetes mellitus: a systematic review, Lancet Neurol, 5, 64, 10.1016/S1474-4422(05)70284-2 Kopf, 2009, Risk of incident Alzheimer’s disease in diabetic patients: a systematic review of prospective trials, J Alzheimer Dis, 16, 677, 10.3233/JAD-2009-1011 Wang, 2012, Risk of Alzheimer’s disease in relation to diabetes: a population-based cohort study, Neuroepidemiology, 38, 237, 10.1159/000337428 Huang, 2014, Diabetes mellitus and the risk of Alzheimer’s disease: a nationwide population-based study, PLoS One, 9 Hugenschmidt, 2014, The cross-sectional and longitudinal associations of diabetic retinopathy with cognitive function and brain MRI findings: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial, Diabetes Care, 37, 3244, 10.2337/dc14-0502 Simó, 2017, Cognitive impairment and dementia: a new emerging complication of type 2 diabetes — the diabetologist’s perspective, Acta Diabetol, 54, 417, 10.1007/s00592-017-0970-5 Sundstrom, 2018, Proteomic analysis of early diabetic retinopathy reveals mediators of neurodegenerative brain diseases, Invest Ophthalmol Vis Sci, 59, 2264, 10.1167/iovs.17-23678 Ciudin, 2017, Retinal microperimetry: a new tool for identifying patients with type 2 diabetes at risk for developing Alzheimer disease, Diabetes, 66, 3098, 10.2337/db17-0382 Simó-Servat, 2019, Usefulness of eye fixation assessment for identifying type 2 diabetic subjects at risk of dementia, J Clin Med, 8, 10.3390/jcm8010059 Cheung, 2007, Is diabetic retinopathy an independent risk factor for ischemic stroke?, Stroke, 38, 398, 10.1161/01.STR.0000254547.91276.50 Rim, 2020, Retinal vascular signs and cerebrovascular diseases, J Neuroophthalmol, 40, 44, 10.1097/WNO.0000000000000888 van Sloten, 2020, Cerebral microvascular complications of type 2 diabetes: stroke, cognitive dysfunction, and depression, Lancet Diabetes Endocrinol, 8, 325, 10.1016/S2213-8587(19)30405-X Exalto, 2014, Severe diabetic retinal disease and dementia risk in type 2 diabetes, J Alzheimers Dis, 42, S109, 10.3233/JAD-132570 Sohn, 2016, Retinal neurodegeneration may precede microvascular changes characteristic of diabetic retinopathy in diabetes mellitus, Proc Natl Acad Sci U S A, 113, E2655, 10.1073/pnas.1522014113 Abramoff, 2018, Approach for a clinically useful comprehensive classification of vascular and neural aspects of diabetic retinal disease, Invest Ophthalmol Vis Sci, 59, 519, 10.1167/iovs.17-21873 Ponirakis, 2019, Association of corneal nerve fiber measures with cognitive function in dementia, Ann Clin Transl Neurol, 6, 689, 10.1002/acn3.746